한글목차

세계의 신생아 황달 치료 시장은 병원 시장과 가정 시장에 기회가 있어 장래성이 기대됩니다. 세계의 신생아 황달 치료 시장은 2025-2031년 연평균 복합 성장률(CAGR) 4.1%를 나타낼 것으로 예측됩니다. 이 시장의 주요 촉진요인은 세계의 신생아 황달의 이환율 증가, 부모 및 건강 관리 제산업체의 의식 증가, 고급 광선 치료 장비의 가용성 증가입니다.

• Lucintel은 유형별로 휴대용 광선 치료기가 예측 기간 동안 높은 성장을 이룰 것으로 예측됩니다.
• 용도별로는 병원이 높은 성장이 예상되고 있습니다.
• 지역별로는 아시아태평양이 예측기간에서 가장 높은 성장이 예상됩니다.

150페이지 이상의 종합적인 보고서를 통해 비즈니스 의사 결정에 도움이 되는 귀중한 인사이트를 얻을 수 있습니다. 몇 가지 인사이트를 포함하는 샘플 다이어그램이 아래에 나와 있습니다.

신생아 황달 치료 시장 새로운 동향

신생아 황달 치료 시장은 기술의 진보, 환자 중심의 케어, 저렴한 솔루션에 대한 세계 수요에 힘입어 미래를 결정하는 다양한 새로운 동향에 휩쓸리고 있습니다.

• LED 광선 치료 기술의 발전 : LED를 사용한 광선 치료 장비의 보급은 중요한 동향입니다. LED는 기존의 형광등에 비해 긴 수명, 에너지 사용량 감소, 치료 파장의 빛을 방출하는 능력 등 몇 가지 장점이 있어 보다 효과적이고 잠재적으로 안전한 빌리루빈의 감소를 기대할 수 있습니다. 이 기술은 병원에서 표준이되고 있으며 휴대용 기기에도 통합되고 있습니다.
• 휴대용 및 가정용 광선 치료 장치 개발 : 의사의 지도하에 가정에서 사용할 수 있는 작고 사용하기 쉬운 광선 치료 장치 개발에 관심이 높아지고 있습니다. 이러한 장비는 빌리루빈 수치가 낮은 신생아에게 효과적인 치료를 제공하는 반면, 입원 기간 단축, 가족 성가신 경감 감소, 건강 관리 비용 절감을 가져올 것으로 기대됩니다. 이를 위해서는 강력한 안전 기능과 가정용 사용에 대한 간단한 지침이 필요합니다.
• 비침습적 빌리루빈 모니터링 통합 : 경피적 빌리루빈 농도계와 같은 비침습적 빌리루빈 측정 장치의 개발과 사용의 확대는 큰 동향입니다. 이들은 채혈을 반복하지 않고 신속하고 고통없이 빌리루빈 농도를 스크리닝하는 데 사용되며 신생아의 스트레스를 최소화하고 필요할 때 적시에 개입 할 수 있습니다. 이 기술은 황달의 조기 진단과 진행을 모니터링하는 데 도움이 됩니다.
• 개별화 및 최적화된 광선요법의 중요성 : 현재의 조사는 임신 월령, 체중, 황달의 원인 등 개별 신생아의 특징에 따라 광선 요법을 맞춤화하는 것도 강조하고 있습니다. 또한 탈수 및 피부 자극과 같은 부작용을 최소화하면서 빌리루빈을 최대로 줄이기 위해 방사선 조명 수준과 광선 치료 시간을 최적화하는 것이 중요합니다.
• 원격 의료 및 원격 모니터링 솔루션 : 신생아 황달 관리에서 원격 의료 및 원격 모니터링 기술의 활용은 새로운 동향입니다. 이를 통해 의료 서비스 제산업체가 빌리루빈 수치와 치료 경과를 원격으로 모니터링할 수 있습니다. 이를 통해 전문의가 치료에 대한 액세스를 향상시키고 적시에 치료 계획을 조정할 수 있습니다.

이러한 새로운 동향은 신생아 황달 치료 시장을 보다 효율적이고 안전한 환자 중심 솔루션으로 변화시키고 있습니다. LED 기술 개발, 휴대용 장비 개발, 비침습 모니터링, 맞춤형 치료 프로토콜 및 원격 의료 도입은 모두 신생아와 그 가족에게 더 나은 치료 경험과 치료 성적 향상을 향하고 있습니다.

신생아 황달 치료 시장 최근 동향

신생아 황달 치료 시장은 최근의 동향으로서 효능, 안전성, 치료에 대한 접근성 개선에 중점을 둔 몇 가지 주요 발전을 이루고 있습니다.

• 광선 치료 장치의 스펙트럼 출력 최적화 : 광선 치료 장치의 최근 동향은 피부 손상 및 기타 부작용의 위험을 최소화하면서 빌리루빈의 최대 흡수를 달성하기 위해 조사되는 빛의 스펙트럼을 최적화하는 것을 포함합니다. 이것은 빌리루빈을 수용성 이성질체로 전환시키고 배설하는데 가장 효과적인 청록색광의 특정 파장을 적용하는 것을 포함합니다.
• 고휘도 협대역 LED 시스템 개발 : 고강도 좁은 밴드 LED 광선 요법 시스템의 사용은 보다 짧은 시간에 보다 특이적인 빌리루빈 감소를 가능하게 합니다. 이러한 시스템은 치료 빛을 집중적으로 조사하므로 심한 황달을 가진 신생아의 광선 요법 경과 및 입원 기간을 단축할 수 있습니다.
• 광선 치료 장비에 지능형 기능 탑재 : 최신 광선 치료기에는 자동 조사 제어, 치료 시간 모니터링, 기록 로깅 등의 지능형 기능이 탑재되어 있습니다. 이러한 기능을 통해 치료자는 잘 통제된 최대한의 치료를 제공하고 체계적으로 경과를 추적하고 적절한 기록을 확실하게 남길 수 있습니다.
• 광섬유 광치료 담요 개발 : 신생아의 피부에 직접 빛을 조사하는 광섬유 광선요법 담요는 강도와 조사 범위가 개선되었습니다. 담요는 신생아의 취급과 모유 수유가 더 쉬워지는 동시에 24시간 체제에서의 치료에 특히 유용합니다.
• 부모와 간병인을 위한 교육 자료 : 황달이 있는 신생아 가정에서의 돌보는 부모와 간병인이 수행하는 중요한 역할을 인식하고, 신생아의 황달, 관리, 가정용 광선 치료기의 안전한 가정 사용에 대한 광범위한 교육 자료를 만드는 데 중점을 둡니다.

신생아 황달 치료 시장에서 이러한 최근의 발전은 더 나은 더 안전하고 사용하기 쉬운 치료를 제공함으로써 신생아 관리에 큰 영향을 미치고 있습니다. 광출력 극대화, 지능형 기능, 컴팩트한 장비, 교육의 강화가 중시되어 신생아와 그 가족에게 보다 나은 치료 결과와 경험의 향상으로 이어지고 있습니다.

목차

제1장 주요 요약

제2장 세계의 신생아 황달 치료 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• PESTLE 분석
• 특허 분석
• 규제 환경
• 업계의 성장 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 신생아 황달 치료 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 신생아 황달 치료 시장 : 유형별
  • 오버헤드 광선 치료 장치 : 동향과 예측(2019-2031년)
  • 휴대용 광선 치료 장치 : 동향과 예측(2019-2031년)
  • 기타 : 동향과 예측(2019-2031년)
• 세계의 신생아 황달 치료 시장 : 용도별
  • 병원 : 동향과 예측(2019-2031년)
  • 가정 : 동향과 예측(2019-2031년)
  • 기타 : 동향과 예측(2019-2031년)

제4장 시장 동향과 예측 분석 : 지역별(2019-2031년)

• 신생아 황달 치료 시장 : 지역별
• 북미의 신생아 황달 치료 시장
• 유럽의 신생아 황달 치료 시장
• 아시아태평양의 신생아 황달 치료 시장
• 기타 지역의 신생아 황달 치료 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
  • 경쟁 기업 간 경쟁 관계
  • 구매자의 협상력
  • 공급기업의 협상력
  • 대체품의 위협
  • 신규 참가업체의 위협

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 신생아 황달 치료 시장 성장 기회 : 유형별
  • 신생아 황달 치료 시장 성장 기회 : 용도별
  • 신생아 황달 치료 시장 성장 기회 : 지역별
• 세계의 신생아 황달 치료 시장 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 신생아 황달 치료 시장 능력 확대
  • 세계의 신생아 황달 치료 시장 합병, 인수, 합작 사업
  • 인증 및 라이선싱

제7장 주요 기업의 기업 프로파일

• GE Healthcare
• Drager
• Bilimetrix
• Philips
• Atom Medical
• Nice Neotech
• MTTS
• Natus Medical
• Delta
• Micro Lab

영문목차

The future of the global newborn jaundice treatment market looks promising with opportunities in the hospital and household markets. The global newborn jaundice treatment market is expected to grow with a CAGR of 4.1% from 2025 to 2031. The major drivers for this market are the rising incidence of neonatal jaundice worldwide, the growing awareness among parents & healthcare providers, and the increasing availability of advanced phototherapy devices.

• Lucintel forecasts that, within the type category, portable phototherapy unit is expected to witness higher growth over the forecast period.
• Within the application category, hospital is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Newborn Jaundice Treatment Market

The market for newborn jaundice treatment is experiencing various emerging trends that are defining its future, fueled by technological advancements, patient-centered care, and the demand for affordable solutions worldwide.

• LED Phototherapy Technology Advances: The growing use of LED-based phototherapy equipment is a key trend. LEDs have several benefits over conventional fluorescent lamps, such as longer life, reduced energy usage, and the capacity to emit light in therapeutic wavelengths, resulting in more effective and potentially safer bilirubin reduction. This technology is becoming the norm in hospitals and is also being integrated into portable devices.
• Portable and Home-Based Phototherapy Device Development: There is increasing interest in the development of small and easy-to-use phototherapy devices for home use under medical guidance. Such devices are expected to shorten hospital stays, cause less disruption to the family, and reduce healthcare costs while providing effective treatment for newborns with lower bilirubin levels. This necessitates strong safety features and simple instructions for home use.
• Integration of Non-Invasive Bilirubin Monitoring: Development and expanding use of non-invasive bilirubin measuring equipment, like transcutaneous bilirubinometers, is a major trend. These are used to quickly and painlessly screen bilirubin levels without repeated blood sampling, minimizing newborn stress and allowing for timely intervention when required. This technology assists in early diagnosis and monitoring of jaundice progression.
• Emphasis on Personalized and Optimized Phototherapy: Current research is also emphasizing the customization of phototherapy treatment according to individual newborn characteristics, including gestational age, weight, and the cause of jaundice. This also involves optimizing irradiance levels and phototherapy duration to maximize bilirubin reduction with the least possible side effects such as dehydration or skin irritation.
• Telemedicine and Remote Monitoring Solutions: The use of telemedicine and remote monitoring technologies in newborn jaundice care is a new trend. This enables remote monitoring of bilirubin levels and treatment progress by healthcare providers, particularly for newborns undergoing home-based phototherapy. This improves access to specialist care and allows for timely treatment plan adjustments.

These new trends are transforming the market for newborn jaundice treatment towards more efficient, safer, and patient-focused solutions. Progress in LED technology, portable device development, non-invasive monitoring, customized treatment protocols, and telemedicine incorporation are all working towards enhanced outcomes and a better experience for newborns and families.

Recent Developments in the Newborn Jaundice Treatment Market

The newborn jaundice treatment market has seen several key developments recently, focusing on improving the efficacy, safety, and accessibility of care.

• Optimized Spectral Output of Phototherapy Devices: Recent developments in phototherapy equipment include the optimization of the spectrum of light emitted to achieve maximum absorption of bilirubin with minimum risk of skin damage and other side effects. This involves the application of particular wavelengths of blue-green light that are most effective in converting bilirubin to water-soluble isomers for excretion.
• High-Intensity Narrow-Band LED System Development: The availability of high-intensity, narrow-band LED phototherapy systems enables more specific bilirubin reduction within a shorter period. These systems provide a focused dose of therapeutic light, which may shorten the course of phototherapy and hospital stays for newborns with severe jaundice.
• Inclusion of Intelligent Features in Phototherapy Equipment: Contemporary phototherapy equipment is embracing intelligent features including automatic irradiance control, monitoring of treatment times, and record logging. The features enable practitioners to provide well-controlled and maximized treatment, track progress systematically, and ensure proper records are kept.
• Developments in Fiber Optic Phototherapy Blankets: Fiber optic phototherapy blankets, which provide light to the newborn's skin directly, have undergone improvements in intensity and coverage. Blankets are especially convenient for around-the-clock treatment while enabling greater ease in handling and feeding the newborn.
• Educational Resources for Parents and Caregivers: In an acknowledgment of the critical role played by parents and caregivers in caring for newborns with jaundice at home, there is a focus on creating extensive educational materials regarding newborn jaundice, its management, and safe home use of home phototherapy machines.

These recent advances in the newborn jaundice treatment market are having a profound effect on neonatal care by offering better, safer, and easier-to-use treatment. The emphasis on maximized light output, intelligent features, compact devices, and increased education is leading to better outcomes and an improved experience for newborns and their families.

Strategic Growth Opportunities in the Newborn Jaundice Treatment Market

The market of newborn jaundice treatment poses a number of strategic growth possibilities by fulfilling unserved needs within different healthcare scenarios and patient segments.

• Inauguration of Home-Based Treatment Services: In view of safer and more efficacious portable devices for phototherapy, there remains a huge prospect for the escalation of home-based treatment services of newborns experiencing mild to moderate jaundice. This is likely to decelerate rehospitalization rates, decrease expenditures on healthcare, and enhance the bonding and satisfaction of parents.
• Low-Resource Setting Jaundice Management Solutions Development: The development of affordable, robust, and user-friendly phototherapy devices tailored to low-resource settings, along with training for health workers, can mitigate the huge burden of newborn jaundice in developing nations and enhance access to critical care.
• Well-Baby Clinic Jaundice Screening: Using non-invasive bilirubinometers in well-baby clinics and primary care facilities to perform routine bilirubin screening can enable early detection of jaundice and prompt intervention, preventing severe hyperbilirubinemia and its related problems.
• Personalized Phototherapy Protocols: Leveraging research and data analytics to create individualized phototherapy treatment protocols depending on specific newborn traits will help maximize treatment outcomes and reduce side effects to result in improved results.
• Design of Extensive Jaundice Management Platforms: The establishment of comprehensive, integrated platforms including non-invasive screening instruments, phototherapy lamps with remote monitoring, and education for parents and healthcare providers has the potential to simplify the care of newborn jaundice and enhance coordination among various settings.

These strategic expansion opportunities in the newborn jaundice treatment market are centered around enhancing accessibility, affordability, and personalization of care. By scaling up home-based services, creating solutions for low-resource environments, integrating screening into routine practice, personalizing treatment protocols, and building comprehensive management platforms, the market can have a very significant influence on the health and well-being of newborns around the world.

Newborn Jaundice Treatment Market Driver and Challenges

The key drivers for the newborn jaundice treatment market are the high prevalence of neonatal jaundice worldwide, growing awareness of its possible complications, and improved phototherapy technology. On the other hand, the market has challenges like the expense of advanced treatment equipment, the necessity for efficient screening programs, and maintaining accessibility of treatment in low-resource environments.

The factors responsible for driving the newborn jaundice treatment market include:

1. High Prevalence of Newborn Jaundice: Newborn jaundice is an extremely prevalent condition globally, occurring in a high percentage of newborn babies. This high prevalence makes a large and steady demand for efficient treatment options necessary to avoid bilirubin neurotoxicity.

2. Increasing Awareness of Potential Complications: Increased awareness of healthcare professionals and parents regarding the possible long-term neurological complications of untreated severe jaundice (kernicterus) is fueling demand for early detection and successful treatment interventions.

3. Advances in Phototherapy Technology: Ongoing innovations in phototherapy equipment, specifically the advancement of more effective and safer LED-based systems, are fueling market growth through improved treatment results and fewer side effects.

4. Focus on Early Detection and Intervention: Healthcare recommendations and guidelines more and more focus on the need for early bilirubin screening and timely phototherapy initiation if necessary, thus increasing the need for bilirubin measurement devices and phototherapy machines.

5. Government and Healthcare Initiatives: Government and healthcare agencies are launching programs and guidelines to enhance newborn care, such as jaundice management, which typically entails investments in treatment and screening infrastructure.

Challenges in the newborn jaundice treatment market are:

1. Advanced Treatment Devices' Cost: High-end phototherapy devices with high-end features and non-invasive bilirubin monitors are costly, thus becoming a deterrent to adoption, especially in settings where resources are limited and small healthcare facilities exist.

2. Demand for Efficient Screening Programs: As important as screening is, organizing and implementing effective and extensive bilirubin screening programs, particularly in developing nations, can prove to be problematic owing to logistic and resource-related limitations.

3. Providing Accessibility in Low-Resource Areas: Facilitating access to the proper jaundice care, especially phototherapy, in remote and underprivileged regions with limited facilities and trained healthcare professionals is a major challenge in the world.

The newborn jaundice treatment market is dominated by the high prevalence of the condition, growing awareness of its hazards, and phototherapy technology advancements. Challenges associated with the expense of sophisticated devices, the implementation of efficient screening programs, and maintaining accessibility in low-resource environments must be met to further enhance outcomes among newborns with jaundice globally.

List of Newborn Jaundice Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies newborn jaundice treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the newborn jaundice treatment companies profiled in this report include-

• GE Healthcare
• Drager
• Bilimetrix
• Philips
• Atom Medical
• Nice Neotech
• MTTS
• Natus Medical
• Delta
• Micro Lab

Newborn Jaundice Treatment Market by Segment

The study includes a forecast for the global newborn jaundice treatment market by type, application, and region.

Newborn Jaundice Treatment Market by Type [Value from 2019 to 2031]:

• Overhead Phototherapy Units
• Portable Phototherapy Units
• Others

Newborn Jaundice Treatment Market by Application [Value from 2019 to 2031]:

• Hospital
• Household
• Others

Newborn Jaundice Treatment Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Newborn Jaundice Treatment Market

Newborn jaundice, a relatively common condition in newborns involving yellowing of the skin and eyes, requires safe and affordable treatment to avoid future neurological issues. New advancements in the treatment of newborn jaundice in the market center on improving the effectiveness and safety of phototherapy, the main treatment. Advancements comprise improvements in light-emitting diode (LED) technology, the introduction of portable and home phototherapy equipment, and enhanced diagnostic equipment for early identification and monitoring of bilirubin levels. This context provides the backdrop for reviewing country-specific advances in this critical area of medicine.

• United States: The United States market focuses on high-technology phototherapy systems with accurate spectral output and control of irradiance to maximize bilirubin decrease with a minimum of possible side effects. New innovations involve embedding these systems into electronic health records for hassle-free data handling and creating user-friendly, hospital-grade phototherapy units for home usage with medical supervision aimed at decreasing hospitalization and healthcare expenditures.
• China: Having a high birth rate, China is a major market for newborn jaundice treatment. New trends include the growing use of LED phototherapy devices instead of conventional fluorescent lamps because they are energy-efficient and have a longer lifespan. Increased emphasis is also being placed on enhancing access to phototherapy in rural regions through the creation of more portable and cheaper treatment methods, combined with better training for healthcare workers in neonatal care.
• Germany: Germany's newborn jaundice treatment market is dominated by emphasis on quality and technologically superior medical devices. Recent advancements involve the introduction of advanced phototherapy units with integrated irradiance sensors and feedback loops to deliver optimal treatment. Research and development activities also focus on the long-term neurodevelopmental outcomes of jaundiced newborns and optimizing treatment protocols based on that.
• India: India faces a substantial burden of newborn jaundice, particularly in rural and underserved communities. Recent advancements include the development of cost-effective and sturdy phototherapy devices appropriate for low-resource settings. Increased focus has also been directed towards community-based jaundice screening initiatives and training of frontline healthcare workers at the primary care level to enable early diagnosis and prompt implementation of phototherapy, enhancing access to basic treatment.
• Japan: The Japanese market places a priority on gentle yet effective newborn care. Recent innovation in jaundice treatment includes improvement of phototherapy protocols to keep treatment times to a minimum and reduce the possibility of newborn stress. In addition, interest in non-invasive bilirubin monitoring instruments for decreased necessity for repeated blood testing, together with the employment of high-grade LED phototherapy equipment with light output optimized for effective and safe reduction of bilirubin, has been demonstrated.

Features of the Global Newborn Jaundice Treatment Market

• Market Size Estimates: Newborn jaundice treatment market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Newborn jaundice treatment market size by type, application, and region in terms of value ($B).
• Regional Analysis: Newborn jaundice treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the newborn jaundice treatment market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the newborn jaundice treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the newborn jaundice treatment market by type (overhead phototherapy units, portable phototherapy units, and others), application (hospital, household, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Newborn Jaundice Treatment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: PESTLE Analysis
• 2.4: Patent Analysis
• 2.5: Regulatory Environment
• 2.6: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Newborn Jaundice Treatment Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Newborn Jaundice Treatment Market by Type
  • 3.3.1: Overhead Phototherapy Units: Trends and Forecast (2019 to 2031)
  • 3.3.2: Portable Phototherapy Units: Trends and Forecast (2019 to 2031)
  • 3.3.3: Others: Trends and Forecast (2019 to 2031)
• 3.4: Global Newborn Jaundice Treatment Market by Application
  • 3.4.1: Hospital: Trends and Forecast (2019 to 2031)
  • 3.4.2: Household: Trends and Forecast (2019 to 2031)
  • 3.4.3: Others: Trends and Forecast (2019 to 2031)

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Newborn Jaundice Treatment Market by Region
• 4.2: North American Newborn Jaundice Treatment Market
  • 4.2.1: North American Market by Type: Overhead Phototherapy Units, Portable Phototherapy Units, and Others
  • 4.2.2: North American Market by Application: Hospital, Household, and Others
  • 4.2.3: The United States Newborn Jaundice Treatment Market
  • 4.2.4: Mexican Newborn Jaundice Treatment Market
  • 4.2.5: Canadian Newborn Jaundice Treatment Market
• 4.3: European Newborn Jaundice Treatment Market
  • 4.3.1: European Market by Type: Overhead Phototherapy Units, Portable Phototherapy Units, and Others
  • 4.3.2: European Market by Application: Hospital, Household, and Others
  • 4.3.3: German Newborn Jaundice Treatment Market
  • 4.3.4: French Newborn Jaundice Treatment Market
  • 4.3.5: Spanish Newborn Jaundice Treatment Market
  • 4.3.6: Italian Newborn Jaundice Treatment Market
  • 4.3.7: The United Kingdom Newborn Jaundice Treatment Market
• 4.4: APAC Newborn Jaundice Treatment Market
  • 4.4.1: APAC Market by Type: Overhead Phototherapy Units, Portable Phototherapy Units, and Others
  • 4.4.2: APAC Market by Application: Hospital, Household, and Others
  • 4.4.3: Japanese Newborn Jaundice Treatment Market
  • 4.4.4: Indian Newborn Jaundice Treatment Market
  • 4.4.5: Chinese Newborn Jaundice Treatment Market
  • 4.4.6: South Korean Newborn Jaundice Treatment Market
  • 4.4.7: Indonesian Newborn Jaundice Treatment Market
• 4.5: ROW Newborn Jaundice Treatment Market
  • 4.5.1: ROW Market by Type: Overhead Phototherapy Units, Portable Phototherapy Units, and Others
  • 4.5.2: ROW Market by Application: Hospital, Household, and Others
  • 4.5.3: Middle Eastern Newborn Jaundice Treatment Market
  • 4.5.4: South American Newborn Jaundice Treatment Market
  • 4.5.5: African Newborn Jaundice Treatment Market

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Newborn Jaundice Treatment Market by Type
  • 6.1.2: Growth Opportunities for the Global Newborn Jaundice Treatment Market by Application
  • 6.1.3: Growth Opportunities for the Global Newborn Jaundice Treatment Market by Region
• 6.2: Emerging Trends in the Global Newborn Jaundice Treatment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Newborn Jaundice Treatment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Newborn Jaundice Treatment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: GE Healthcare
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.2: Drager
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.3: Bilimetrix
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.4: Philips
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.5: Atom Medical
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.6: Nice Neotech
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.7: MTTS
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.8: Natus Medical
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.9: Delta
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.10: Micro Lab
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing